Literature DB >> 2476123

Investigation of the stereochemical course of DNA synthesis catalysed by human immunodeficiency virus type 1 reverse transcriptase.

S Hopkins1, P A Furman, G R Painter.   

Abstract

The Sp-isomer of thymidine 5'-O-(1-thiotriphosphate) is used as substrate by HIV-1 reverse transcriptase. The absolute configuration of the internucleotide linkage in the oligonucleotide product was identified by 31p NMR spectroscopy to be the Rp-isomer, indicating that incorporation of dTTP alpha S into the oligonucleotide proceeded with inversion of configuration at the alpha-phosphorus. The mechanistic implications of these observations are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476123     DOI: 10.1016/0006-291x(89)92105-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection.

Authors:  Shalley N Kudalkar; Jagadish Beloor; Elias Quijano; Krasimir A Spasov; Won-Gil Lee; José A Cisneros; W Mark Saltzman; Priti Kumar; William L Jorgensen; Karen S Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-26       Impact factor: 11.205

2.  Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucleoside Inhibitors and Their Interactions With HIV-1 Reverse Transcriptase.

Authors:  Kathleen M Frey; Nicole Bertoletti; Albert H Chan; Joseph A Ippolito; Mariela Bollini; Krasimir A Spasov; William L Jorgensen; Karen S Anderson
Journal:  Front Mol Biosci       Date:  2022-02-14

3.  Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core.

Authors:  Alex K K Leung; Ismail M Hafez; Svetlana Baoukina; Nathan M Belliveau; Igor V Zhigaltsev; Elham Afshinmanesh; D Peter Tieleman; Carl L Hansen; Michael J Hope; Pieter R Cullis
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2012-07-18       Impact factor: 4.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.